Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Ofer Purim"'
Autor:
Waleed Kian, Bilal Krayim, Hadel Alsana, Betsy Giles, Ofer Purim, Wafeek Alguayn, Farouq Alguayn, Nir Peled, Laila C. Roisman
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Lung cancer is the most common cancer-related cause of death worldwide, most of which are non-small cell lung cancers (NSCLC). Epidermal growth factor receptor (EGFR) mutations are common drivers of NSCLC. Treatment plans for NSCLC, specifically aden
Externí odkaz:
https://doaj.org/article/6868af2f25d84da6a90cf2804406ca92
Autor:
Baruch Brenner, Michal Sarfaty, Ofer Purim, Yulia Kundel, Limor Amit, Amir Abramovich, Udi Sadeh Gonik, Efraim Idelevich, Noa Gordon, Gal Medalia, Aaron Sulkes
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0157548 (2016)
Current treatment options for advanced esophagogastric cancer (AEGC) are still unsatisfactory. The aim of this prospective phase Ib/II study was to evaluate the safety and efficacy of a novel regimen, AVDCX, consisting of weekly docetaxel and cisplat
Externí odkaz:
https://doaj.org/article/88de818c807e42978bce4763baaf7652
Autor:
Yulia Kundel, Nicola J Nasser, Ofer Purim, Rinat Yerushalmi, Eyal Fenig, Raphael M Pfeffer, Salomon M Stemmer, Shulamith Rizel, Zvi Symon, Bella Kaufman, Aaron Sulkes, Baruch Brenner
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68327 (2013)
Pain from bone metastases of breast cancer origin is treated with localized radiation. Modulating doses and schedules has shown little efficacy in improving results. Given the synergistic therapeutic effect reported for combined systemic chemotherapy
Externí odkaz:
https://doaj.org/article/1412513b190143dab8f7c54be817b51c
Autor:
Eyal Mor, Dan Assaf, Shachar Laks, Efrat Keren Gilat, David Hazzan, Einat Shacham-Shmueli, Ofer Margalit, Naama Halpern, Tamar Beller, Ben Boursi, Ofer Purim, Daria Perelson, Douglas Zippel, Mohammad Adileh, Aviram Nissan, Almog Ben-Yaacov
Publikováno v:
Journal of Gastrointestinal Surgery. 27:131-140
Constraints of pelvic anatomy render complete cytoreduction (CRS) challenging. The aim of this study is to investigate the impact of pelvic peritonectomy during CRS/HIPEC on colorectal peritoneal metastasis (CRPM) patients' outcomes.This is a retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f7c4965a4d3b28d5a5d3856b7c6af0
https://doi.org/10.1007/s11605-022-05501-y
https://doi.org/10.1007/s11605-022-05501-y
Autor:
Eli Sapir, Raphael Pfeffer, Marc Wygoda, Ofer Purim, Adi Levy, Benjamin Corn, Yasmine Amitay, Patricia Ohana, Alberto Gabizon
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d5bfcd7a3d00ed67ab16669e9a45056e
https://doi.org/10.1016/j.ijrobp.2023.03.046
https://doi.org/10.1016/j.ijrobp.2023.03.046
Autor:
Eyal Mor, Ofer Purim, Naama Halpern, Einat Shacham-Shmueli, Dov Zippel, Ben Boursi, Michael Goldenshluger, Mohammad Adileh, Aviram Nissan, Gal Schtrechman, David Hazzan, Ofer Margalit, Yehonatan Nevo, Lior Segev, Almog Ben-Yaacov, Shachar Laks
Publikováno v:
European Journal of Surgical Oncology. 47:2933-2938
Peritoneal Cancer Index (PCI) and complete cytoreduction are the best outcome predictors following cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Lesions in critical areas, regardless of PCI, complicate surgery an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471ec067dba9599d5b97ca6bf642b792
https://doi.org/10.1016/j.ejso.2021.05.022
https://doi.org/10.1016/j.ejso.2021.05.022
Autor:
Shani Goren, Naama Halpern, Aviram Nissan, Daria Perelson, Gal Schtrechman, Mohammad Adileh, Vyacheslav Ivanov, Almog Ben-Yaacov, Ofer Purim, Dan Aderka, Shachar Laks, Einat Shacham-Shmueli
Publikováno v:
Annals of Surgical Oncology. 28:5330-5338
Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) for colorectal cancer peritoneal metastases (CRPM) is associated with improved survival in patients with historically dismal prognosis. Nonetheless, peritoneal recurrences rema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d5f54eceafcd381ff8f95d4d2d59bcd
https://doi.org/10.1245/s10434-021-09684-7
https://doi.org/10.1245/s10434-021-09684-7
Autor:
Irit Ben-Aharon, Hadas Prag-Naveh, Nir Peled, Salomon M. Stemmer, E. Hodak, Dov Flex, Baruch Brenner, Batya Davidovici, Aron Popovtzer, Ofer Purim, Igor Snast, Iris Amitay-Laish, Michael David, Yael Anne Leshem, Ayelet Ollech
Publikováno v:
Dermatology. 237:988-994
Background: The incidence of epidermal growth factor receptor inhibitor (EGFRI)-induced papulopustular rash is 60–85%. Objective: To investigate prophylactic topical treatment for EGFRI-induced rash. Methods: A single-center, randomized, double-bli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c150ed3926bc7bc2b4df9cc7a9c9ce
https://doi.org/10.1159/000511869
https://doi.org/10.1159/000511869
Autor:
Eyal Mor, Shanie Shemla, Dan Assaf, Shachar Laks, Haggai Benvenisti, David Hazzan, Mai Shiber, Einat Shacham-Shmueli, Ofer Margalit, Naama Halpern, Ben Boursi, Tamar Beller, Daria Perelson, Ofer Purim, Douglas Zippel, Almog Ben-Yaacov, Aviram Nissan, Mohammad Adileh
Publikováno v:
Annals of surgical oncology. 29(13)
Small-bowel obstruction (SBO) after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is a common complication associated with re-admission that may alter patients' outcomes. Our aim was to characterize and investigate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a5253d71b896769d0955a1769db3517
https://pubmed.ncbi.nlm.nih.gov/36018523
https://pubmed.ncbi.nlm.nih.gov/36018523
Autor:
Yaacov Richard Lawrence, Sivan Lieberman, Ilanit Redinsky, Nir Honig, Einat Shacham-Shmueli, Naama Halpern, Stephen Raskin, Damien Urban, Aliza Ackerstein, Maoz Ben-Ayun, Katerina Shulman, Eitan Ben-Ami, Valeriya Semenisty, Ofer Purim, Nirit Yarom, Talia Golan, Ben Boursi, Lina Ziegler, Art M. Krieg, Ofer Margalit
Publikováno v:
Journal of Clinical Oncology. 41:123-123
123 Background: Microsatellite stable (MSS) or mismatch repair proficient (MMR-P) metastatic colorectal cancer is refractory to immune checkpoint inhibition. We hypothesized that a combination of intratumoral TLR9 agonist, radiosurgery and dual PD-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f99604bbfcc4c1abb1dcf94d0a71850a
https://doi.org/10.1200/jco.2023.41.4_suppl.123
https://doi.org/10.1200/jco.2023.41.4_suppl.123